Christof Kazda

3PUBLICATIONS
4CO-AUTHORS
Radiation therapyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 14, 2025
Orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist, improves markers of β-cell function and insulin sensitivity in type 2 diabetes.

Julio Rosenstock, Deborah A Robins, Kevin L Duffin

|Oct 04, 2021
Ultra-rapid lispro shows faster pharmacokinetics and reduces postprandial glucose excursions versus Humalog® in patients with type 2 diabetes mellitus in a randomized, controlled crossover meal test early phase study.

Jennifer Leohr, Christof Kazda, Rong Liu

|Oct 01, 2021
Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog® in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study.

Christof Kazda, Jennifer Leohr, Rong Liu

Pageof 1

Frequent Collaborators

2 joint publications

Jennifer Leohr

1 joint publications

Christoph Kapitza

1 joint publications

Julio Rosenstock

1 joint publications

Kieren J Mather